Skip to main content
Journal of Clinical Microbiology logoLink to Journal of Clinical Microbiology
. 1986 Sep;24(3):431–434. doi: 10.1128/jcm.24.3.431-434.1986

Clinical trial comparing bacitracin with Strep-A-Chek for accuracy and turnaround time in the presumptive identification of Streptococcus pyogenes.

D M Yajko, J Lawrence, P Nassos, J Young, W K Hadley
PMCID: PMC268928  PMID: 3531230

Abstract

In a clinical trial, Strep-A-Chek (a 10-min chromogenic test) was compared with the bacitracin disk susceptibility test for accuracy and turnaround time in the presumptive identification of Streptococcus pyogenes. Among 461 isolates of beta-hemolytic streptococci (344 throat isolates and 117 isolates from other sites), 303 group A S. pyogenes isolates were found. The sensitivities of the Strep-A-Chek and bacitracin tests were high (96.4 and 100%, respectively), but the bacitracin test had a lower specificity (84.2%) than the Strep-A-Chek test (98.7%). The predictive values for positive and negative test results were 99.3 and 93.4%, respectively, for Strep-A-Chek and 92.4 and 100%, respectively, for bacitracin. Strep-A-Chek correctly identified all isolates upon repeat testing. All bacitracin tests were performed on subcultures of isolates from the primary plate. Strep-A-Chek testing was performed on colonies from the primary plate when isolated colonies were available. This shortened the turnaround time for Strep-A-Chek compared with bacitracin by at least 24 h on nearly one-half (45%) of the isolates. A peripheral finding of this study was that sulfamethoxazole-trimethoprim blood agar offered no advantage over conventional blood agar with regard to the number of false-positive bacitracin tests obtained from each medium.

Full text

PDF
431

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Facklam R. R., Padula J. F., Thacker L. G., Wortham E. C., Sconyers B. J. Presumptive identification of group A, B, and D streptococci. Appl Microbiol. 1974 Jan;27(1):107–113. doi: 10.1128/am.27.1.107-113.1974. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Facklam R. R., Thacker L. G., Fox B., Eriquez L. Presumptive identification of streptococci with a new test system. J Clin Microbiol. 1982 Jun;15(6):987–990. doi: 10.1128/jcm.15.6.987-990.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Gunn B. A., Ohashi D. K., Gaydos C. A., Holt E. S. Selective and enhanced recovery of group A and B streptococci from throat cultures with sheep blood agar containing sulfamethoxazole and trimethoprim. J Clin Microbiol. 1977 Jun;5(6):650–655. doi: 10.1128/jcm.5.6.650-655.1977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Gunn B. A. SXT and Taxo A disks for presumptive identification of group A and B streptococci in throat cultures. J Clin Microbiol. 1976 Aug;4(2):192–193. doi: 10.1128/jcm.4.2.192-193.1976. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Kurzynski T., Meise C., Daggs R., Helstad A. Improved reliability of the primary plate bacitracin test on throat cultures with sulfamethoxazole-trimethoprim blood agar plates. J Clin Microbiol. 1979 Jan;9(1):144–146. doi: 10.1128/jcm.9.1.144-146.1979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Lawrence J., Yajko D. M., Hadley W. K. Incidence and characterization of beta-hemolytic Streptococcus milleri and differentiation from S. pyogenes (group A), S. equisimilis (group C), and large-colony group G streptococci. J Clin Microbiol. 1985 Nov;22(5):772–777. doi: 10.1128/jcm.22.5.772-777.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Pollock H. M., Dahlgren B. J. Distribution of streptococcal groups in clinical specimens with evaluation of bacitracin screening. Appl Microbiol. 1974 Jan;27(1):141–143. doi: 10.1128/am.27.1.141-143.1974. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Microbiology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES